http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104341425-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5805227aef9b285998ba484773644708
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
filingDate 2013-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb7257b6abb51995280d8f9a4453051a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1e5fee5bac7bb2705f131bb4e343d88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce545472f8d20366a4ae8d428a9bf13a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_debf748c8e60b6178544c6bf7b9b604e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1336d6d1a9fdaae837cc3026c050de0e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc15e41168953dc108a41ffc608a339b
publicationDate 2015-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-104341425-A
titleOfInvention Deuterated acetylene derivatives, pharmaceutical compositions and applications thereof
abstract The invention discloses a deuterated acetylene derivative, its pharmaceutical composition and application. The pharmaceutical composition comprises a therapeutically effective amount of deuterated acetylene derivative (I), its pharmaceutically acceptable salt, stereoisomer, solvate, polymorph, tautomer, metabolite and its One or more of the prodrugs, and at least one pharmaceutically acceptable auxiliary material. The present invention also provides the deuterated acetylene derivative (I), its pharmaceutically acceptable salt, stereoisomer, solvate, polymorph, tautomer, metabolite or its prodrug, Or the application of the pharmaceutical composition in the preparation of one or more protein kinase inhibitors, and the application in the preparation of drugs for treating and/or preventing tumors. The deuterated acetylene derivative (I) of the present invention can effectively inhibit the activity of more than one protein kinase and the growth of tumor cells, and exhibit excellent pharmacokinetic properties and in vitro and in vivo drug effects. (I)
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022053014-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112237579-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107698593-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105198743-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3849985-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112237579-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112939729-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106565600-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106588673-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021114020-A1
priorityDate 2013-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101489558-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101389338-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010221221-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163869880
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465098249
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465434036
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465433118
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11829656
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465321836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426184466
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163520208
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID427846257
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163754713
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468023021
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163715822
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163676842
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13614033
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467925302
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465377738
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426205964
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67506297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466897869
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163754095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465726171
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163955611
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465600955

Total number of triples: 59.